LATS1/2 Kinases in the Hippo Pathway: Regulating Intestinal Stem Cell Fate and Wnt Signaling Crosstalk

Concept

Large Tumor Suppressor Kinases 1 and 2 (LATS1/2) are the core serine/threonine kinases of the evolutionarily conserved Hippo signaling pathway, with LATS1 Ser909 and LATS2 Ser872 as critical phosphorylation sites that mark their enzymatic activation. As key regulators of organ size, tissue homeostasis, stem cell fate, and tumorigenesis, LATS1/2 exert their biological functions by phosphorylating and inactivating the downstream transcriptional coactivators YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif), mediating cytoplasmic retention and degradation of YAP/TAZ to inhibit cell proliferation and guide fate determination. In the intestinal epithelium—one of the body’s most rapidly renewing tissues—LATS1/2 orchestrates the balance of intestinal stem cell (ISC) self-renewal, proliferation, and differentiation through intricate crosstalk with the Wnt/β-catenin signaling pathway, acting as a "bidirectional regulator" to maintain intestinal homeostasis and prevent abnormal hyperplasia and tumorigenesis.

Research Frontier

Contemporary research on LATS1/2 and Hippo-Wnt signaling crosstalk is advancing at the intersection of stem cell biology, developmental biology, and cancer research, with four key frontier directions driving mechanistic discovery and translational application:

1. Deciphering Cell-Type-Specific Hippo-Wnt Crosstalk: Elucidating the distinct regulatory mechanisms of LATS1/2 in ISCs, transit-amplifying progenitors, and differentiated intestinal epithelial cells, and identifying niche-derived signals that modulate LATS1/2 activity in the intestinal crypt microenvironment.
2. Unraveling TEAD-Dependent and Independent YAP/TAZ Functions: Investigating the molecular basis of LATS1/2-mediated YAP/TAZ regulation in TEAD-independent Wnt inhibition and TEAD-dependent pro-proliferative signaling, and identifying novel YAP/TAZ interactors (e.g., TLE corepressors) that mediate pathway crosstalk.
3. Targeting TEAD Palmitoylation for Cancer Therapy: Developing novel, reversible small-molecule inhibitors of TEAD palmitoylation to block YAP/TAZ-TEAD-driven abnormal proliferation, and evaluating their efficacy in intestinal and other Hippo pathway-dysregulated malignancies (e.g., liver, breast cancer).
4. Dynamic Monitoring of Hippo Pathway Activation: Engineering high-sensitivity tools to track LATS1/2 phosphorylation (Ser909/872) and YAP/TAZ subcellular localization in real time, enabling the characterization of Hippo pathway dynamics in physiological and pathological intestinal processes (e.g., regeneration, inflammation, tumorigenesis).

Cutting-edge studies also focus on the epigenetic and post-translational regulation of LATS1/2, and the role of Hippo-Wnt crosstalk in intestinal regeneration after injury and inflammatory bowel disease.

Research Significance

In-depth investigation of LATS1/2-mediated regulation of intestinal stem cell fate and Hippo-Wnt signaling crosstalk has profound scientific and translational significance for stem cell biology, tissue homeostasis, and oncology:

• Stem Cell and Developmental Biology: Uncovering the bidirectional regulatory role of LATS1/2 in ISC maintenance and crypt proliferation deepens our understanding of the complex signaling networks that govern stem cell fate in rapidly renewing tissues, providing a paradigm for studying stem cell regulation in other epithelial systems (e.g., skin, mammary gland).
• Tissue Homeostasis and Regeneration: Elucidating LATS1/2’s function in balancing intestinal epithelial renewal and preventing abnormal hyperplasia reveals key molecular mechanisms of intestinal homeostasis, offering new insights into how the gut responds to injury, inflammation, and environmental stress.
• Colorectal Cancer Research and Therapy: Identifying the TEAD-dependent pro-proliferative role of YAP/TAZ in LATS1/2-deficient intestinal cells and the potential of TEAD palmitoylation inhibition as a therapeutic strategy provides novel molecular targets for colorectal cancer—one of the most common and lethal malignancies worldwide.
• Signaling Pathway Crosstalk: Defining the TEAD-independent mechanism of YAP/TAZ-mediated Wnt inhibition challenges traditional notions of Hippo pathway function and uncovers a new mode of signaling crosstalk, expanding our understanding of how multiple pathways integrate to regulate cell fate and tissue physiology.

Hippo-Wnt Signaling Crosstalk in Intestinal Homeostasis

The intestinal epithelium’s dynamic homeostasis is governed by the intricate crosstalk between the Hippo pathway (via LATS1/2) and the Wnt/β-catenin pathway—the two core signaling networks regulating ISC function and crypt proliferation:

1. Wnt/β-Catenin: The Core Driver of ISC Stemness: The Wnt pathway is indispensable for maintaining ISC stemness, driving crypt cell proliferation, and supporting intestinal epithelial renewal. Constitutive Wnt activation is a hallmark of colorectal cancer, while Wnt inhibition leads to ISC loss and impaired intestinal homeostasis.
2. LATS1/2: A Bidirectional Regulator of Intestinal Homeostasis: As the core kinases of the Hippo pathway, LATS1/2 play two opposing yet complementary roles in the intestine: they are required to maintain Wnt pathway activity and the ISC pool, while also restricting abnormal crypt hyperplasia by inhibiting pro-proliferative signals. This bidirectional regulation ensures the precise balance of intestinal epithelial renewal and prevents uncontrolled cell growth.
3. The Paradox of LATS1/2 Deletion: Conditional knockout of Lats1/2 in intestinal epithelial cells results in two seemingly contradictory phenotypes—ISC loss (caused by impaired Wnt signaling) and crypt expansion (independent of canonical Wnt signaling)—directly demonstrating LATS1/2’s dual functional role and the complexity of Hippo-Wnt crosstalk.

Molecular Mechanisms of LATS1/2-Mediated Regulation in the Intestine

LATS1/2 regulate intestinal stem cell fate and crypt proliferation through two distinct, molecularly separable mechanisms, both dependent on YAP/TAZ but differing in their requirement for the transcription factor TEAD:

1. YAP/TAZ-Dependent, TEAD-Independent Wnt Signaling Inhibition: LATS1/2 deletion leads to dephosphorylation and nuclear translocation of YAP/TAZ, which bind to the transcriptional corepressor TLE (Groucho/Transducin-Like Enhancer of Split)—a key repressor of Wnt pathway effector TCF (T-cell factor). This YAP/TAZ-TLE interaction enhances TLE’s inhibitory activity toward TCF-mediated transcriptional complexes, blocking the expression of Wnt target genes (e.g., Lgr5, Axin2) and ultimately leading to ISC loss and Wnt pathway inactivation. This mechanism challenges the classic model that YAP/TAZ function is exclusively TEAD-dependent.
2. YAP/TAZ-TEAD-Dependent Pro-Proliferative Signaling Activation: The abnormal intestinal crypt expansion induced by LATS1/2 deletion is mediated by the nuclear YAP/TAZ-TEAD transcriptional complex. TEAD’s transcriptional activity is dependent on its palmitoylation modification; small-molecule inhibitors that specifically block TEAD palmitoylation effectively suppress YAP/TAZ-TEAD-driven cell proliferation and proto-oncogene Myc upregulation in LATS1/2-deficient cells. In Apc-mutant intestinal cancer models (mimicking human colorectal cancer), simultaneous inhibition of LATS and TEAD potently curbs tumor hyperproliferation, validating TEAD palmitoylation as a promising therapeutic target for Hippo-Wnt dysregulated malignancies.

LATS1/2 (Ser909/872) Phosphorylation Antibody: A Core Tool for Hippo Pathway Research

The enzymatic activity of LATS1/2 is strictly dependent on the phosphorylation of their activation loop sites—LATS1 Ser909 and LATS2 Ser872—catalyzed by the upstream MST1/2-SAV1 complex. A highly specific Phospho-LATS1/2 (Ser909/872) antibody is an indispensable research tool for studying Hippo pathway function, with three core applications in mechanistic and translational research:

1. Precise Assessment of Hippo Pathway Activation State: The antibody directly detects the phosphorylation level of LATS1/2 (Ser909/872), serving as a gold-standard readout for Hippo pathway core kinase cascade activity in physiological (e.g., intestinal development, homeostasis) and pathological (e.g., inflammation, tumorigenesis) conditions.
2. Deciphering Signaling Pathway Crosstalk: By quantifying p-LATS1/2 (Ser909/872) levels, researchers can establish regulatory connections between the Hippo pathway and other signaling networks (Wnt, GPCR, mechanical stress, inflammatory signals) and identify upstream modulators of LATS1/2 activity.
3. Validating Genetic and Pharmacological Interventions: The antibody confirms the loss of LATS1/2 kinase activity in Lats1/2 knockout/knockdown models and serves as a key pharmacodynamic readout for screening and evaluating Hippo pathway agonists/inhibitors (e.g., MST1/2 activators), enabling the validation of targeted therapeutic strategies.

Product Application: ANT BIO PTE. LTD. Reagents for Hippo Pathway and Intestinal Stem Cell Research

As a leading provider of life science research reagents, ANT BIO PTE. LTD. offers a high-performance Phospho-LATS1/2 (Ser909/872) Recombinant Rabbit Monoclonal Antibody under its STARTER sub-brand—its specialized antibody division—engineered to support cutting-edge research on the Hippo pathway, intestinal stem cell biology, and signaling crosstalk. Developed via advanced recombinant rabbit monoclonal antibody technology and rigorously validated across Western Blot (WB) and immunofluorescence (IF) platforms, this antibody is a gold-standard tool for detecting LATS1/2 activation and studying Hippo pathway function in cell growth regulation, tissue homeostasis, and tumorigenesis.

Core Product Portfolio Advantages

• Ultra-High Phosphorylation Site Specificity: Precisely recognizes the conserved LATS1 Ser909 and LATS2 Ser872 phosphorylation sites in the kinase activation loop—an exclusive marker of LATS1/2 enzymatic activation—with no cross-reactivity to non-phosphorylated LATS1/2 or other Hippo pathway kinases, ensuring accurate detection of Hippo pathway core activity.
• Superior Stability and Batch Consistency: Manufactured under stringent quality control standards, the antibody exhibits exceptional physicochemical stability and minimal inter-batch variation, delivering reliable and reproducible results across diverse experimental conditions and long-term research projects.
• Multi-Platform Validation: Rigorously tested and optimized for Western Blot (WB) and immunofluorescence (IF) applications, supporting both in vitro cell culture studies and in vivo tissue analysis (e.g., intestinal crypt sections) for comprehensive Hippo pathway characterization.
• Direct Indicator of Hippo Pathway Activity: Detects the MST1/2-mediated phosphorylation of LATS1/2—the critical step in Hippo pathway activation—providing a direct readout for monitoring core kinase cascade activity and downstream YAP/TAZ regulation.

Key Application Scenarios for ANT BIO PTE. LTD. Phospho-LATS1/2 (Ser909/872) Antibody

• Hippo Pathway Mechanistic Research: Monitor LATS1/2 activation in response to cell density, cell-cell contact, mechanical stress, and upstream signaling (GPCR, MST1/2) to characterize core Hippo pathway transduction mechanisms.
• Intestinal Stem Cell and Homeostasis Studies: Analyze LATS1/2 phosphorylation dynamics in intestinal crypts, ISCs, and differentiated epithelial cells to investigate Hippo-Wnt signaling crosstalk and intestinal homeostasis regulation.
• Cancer Biology and Therapeutic Research: Evaluate Hippo pathway inactivation (reduced p-LATS1/2 levels) in colorectal, liver, breast, and glioma tumors; validate the efficacy of TEAD palmitoylation inhibitors and other Hippo pathway-targeted therapeutic strategies.
• Tissue Regeneration and Organ Size Control: Explore the role of LATS1/2 activation in organ size regulation, tissue regeneration after injury, and developmental biology across diverse model systems (mouse, organoid, zebrafish).
• Signaling Pathway Crosstalk Analysis: Study how Wnt, inflammatory, and nutritional signals modulate LATS1/2 phosphorylation to establish molecular connections between the Hippo pathway and other key cell fate-regulating networks.

ANT BIO PTE. LTD. provides comprehensive professional technical support for this antibody, including optimized WB/IF experimental protocols, p-LATS1/2 dynamics analysis under different cell stimuli, correlation analysis guidelines with downstream p-YAP (S127) detection, and one-on-one technical consultations—empowering researchers to achieve precise and reliable discoveries in Hippo pathway biology, stem cell research, and oncology.

Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.